Innovation Pipeline: Examining Modern Medicine

August 1, 2017
San Francisco

With changing technological advances as part of its DNA, San Francisco is turning its attention to medicine. As it does, ideas sourced by nearby talent pools and ample venture capital investment will strengthen the innovation pipeline bringing about new breakthroughs in medicine.

In the third event of the “Examining Modern Medicine” series, The Atlantic gathered stakeholders, original thinkers and trailblazers from the nation’s innovation capital to explore what it means to put the bio into biotech. Where is the industry headed and what are the moonshots coming out of the Bay Area that could change the world of medicine?


Watch full session videos

Presented by

Atlantic Live

Speakers

Agenda

  • Tuesday, August 01
  • 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:35 a.m.The Innovation LandscapeRegis Kelly, OBE, Executive Director, QB3; Byers Family Distinguished Professor, UCSF
    Sara Radcliffe, President and CEO, California Life Sciences Association
    Harold Selick, Vice Chancellor, Business Development, Innovation and Partnerships, UCSF
    With Alexis Madrigal, Staff Writer, The Atlantic
  • 9:15 a.m.Making a Bet on BiotechLeon Chen, Venture Partner, OrbiMed
    Carol Gallagher, Partner, New Enterprise Associates Inc.
    Andrew Schiff, ManagingPartner, Aisling Capital
    With Steve Clemons, Washington Editor at Large, The Atlantic
  • 9:45 a.m.The Biotech PlayersCary Gunn, CEO and Founder, Genalyte
    Sean Harper, Executive Vice President, Research and Development, Amgen
    Gabe Otte, CEO and Co-Founder, Freenome
    Lynn Seely, CEO, Myovant Sciences
    With Alexis Madrigal, The Atlantic
  • 10:15 a.m.What Consumers WantRobin Thurston, CEO, Helix
    With Christina Farr, Health and Technology Reporter, CNBC
  • 10:35 a.m.The Marriage of Big Data and HealthRobert Califf, Advisor, Verily Life Sciences; Professor of Medicine, Duke University; Former Commissioner, FDA
    With Steve Clemons, The Atlantic
  • 11:00 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE

Underwriter

Also in This Series

Upcoming Events